Qiu Yu - Net Worth and Insider Trading

Qiu Yu Net Worth

The estimated net worth of Qiu Yu is at least $0 dollars as of 2024-11-07. Qiu Yu is the Directors, executives of Chongqing Lummy Pharmaceutical and owns about 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) stock worth over $0. Details can be seen in Qiu Yu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Qiu Yu has not made any transactions after 2018-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Qiu Yu

Qiu Yu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Qiu Yu owns 1 companies in total, including Chongqing Lummy Pharmaceutical (SZSE:300006) .

Click here to see the complete history of Qiu Yu’s form 4 insider trades.

Insider Ownership Summary of Qiu Yu

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300006	Chongqing Lummy Pharmaceutical	2018-05-29	Directors & executives

Qiu Yu Latest Holdings Summary

Qiu Yu currently owns a total of 1 stock. Qiu Yu owns 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) as of May 29, 2018, with a value of $0.

Latest Holdings of Qiu Yu

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300006	Chongqing Lummy Pharmaceutical	2018-05-29	0	4.66	0

Holding Weightings of Qiu Yu

Qiu Yu Form 4 Trading Tracker

According to the SEC Form 4 filings, Qiu Yu has made a total of 0 transactions in Chongqing Lummy Pharmaceutical (SZSE:300006) over the past 5 years. The most-recent trade in Chongqing Lummy Pharmaceutical is the sale of 8,105,100 shares on May 29, 2018, which brought Qiu Yu around $45 Million.

Insider Trading History of Qiu Yu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Qiu Yu Trading Performance

GuruFocus tracks the stock performance after each of Qiu Yu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Qiu Yu is 2.11%. GuruFocus also compares Qiu Yu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Qiu Yu within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Qiu Yu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Qiu Yu Ownership Network

Ownership Network List of Qiu Yu

No Data

Ownership Network Relation of Qiu Yu

Qiu Yu Owned Company Details

What does Chongqing Lummy Pharmaceutical do?

Who are the key executives at Chongqing Lummy Pharmaceutical?

Qiu Yu is the Directors & executives of Chongqing Lummy Pharmaceutical. Other key executives at Chongqing Lummy Pharmaceutical include Executives lai wen , Supervisors Yuan Yuan , and Secretary & Director Leng Xue Feng .

Chongqing Lummy Pharmaceutical (SZSE:300006) Insider Trades Summary

Over the past 18 months, Qiu Yu made no insider transaction in Chongqing Lummy Pharmaceutical (SZSE:300006). Other recent insider transactions involving Chongqing Lummy Pharmaceutical (SZSE:300006) include a net purchase of 2,500 shares made by lai wen ,

In summary, during the past 3 months, insiders sold 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) were sold and 2,500 shares were bought by its insiders, resulting in a net purchase of 2,500 shares.

Chongqing Lummy Pharmaceutical (SZSE:300006)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chongqing Lummy Pharmaceutical Insider Transactions

No Available Data

Qiu Yu Mailing Address

Above is the net worth, insider trading, and ownership report for Qiu Yu. Currently GuruFocus does not have mailing address information for Qiu Yu.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.